CDK2 and osteosarcoma: Colony formation and CCK8 assays revealed that BMS-794833 inhibited the proliferation of osteosarcoma cells in the shNC group; however, these inhibitory effects were not significant in the sh-CDK2 group (Fig. 3D-E).